Svb Wealth LLC Gilead Sciences, Inc. Transaction History

Svb Wealth LLC

$117 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $3,220 - $3,716	51 Added 0.07%	69,365 $4.76 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $214,811 - $261,957	-3,001 Reduced 4.15%	69,314 $5.08 Million
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $194,092 - $220,105	-2,649 Reduced 3.53%	72,315 $5.86 Million
Q3 2023 Oct 23, 2023	SELL	$73.94 - $80.67 $98,635 - $107,613	-1,334 Reduced 1.75%	74,964 $5.62 Million
Q2 2023 Jul 24, 2023	SELL	$76.01 - $86.7 $99,877 - $113,923	-1,314 Reduced 1.69%	76,298 $5.88 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $313,260 - $356,900	-4,052 Reduced 4.96%	77,612 $6.44 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $41,754 - $59,944	-670 Reduced 0.81%	81,664 $7.01 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $557,234 - $636,505	9,359 Added 12.82%	82,334 $5.08 Million
Q2 2022 Aug 16, 2022	BUY	$57.72 - $65.01 $94,083 - $105,966	1,630 Added 2.28%	72,975 $4.51 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $285,371 - $357,601	4,927 Added 7.42%	71,345 $4.24 Million
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $77,336 - $87,778	-1,192 Reduced 1.76%	66,418 $4.82 Million
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $87,455 - $94,354	-1,292 Reduced 1.88%	67,610 $4.72 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $12,503 - $13,661	197 Added 0.29%	68,902 $4.75 Million
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $292,860 - $334,153	-4,881 Reduced 6.63%	68,705 $4.44 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $145,193 - $165,441	2,563 Added 3.61%	73,586 $4.29 Million
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $322,733 - $405,781	-5,197 Reduced 6.82%	71,023 $4.49 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $408,721 - $474,600	-5,650 Reduced 6.9%	76,220 $5.86 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $864,294 - $1.11 Million	-13,800 Reduced 14.42%	81,870 $6.12 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $753,181 - $828,474	-12,223 Reduced 11.33%	95,670 $6.22 Million
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $6,563 - $7,245	105 Added 0.1%	107,893 $6.84 Million
Q2 2019 Jul 10, 2019	SELL	$61.87 - $69.38 $491,990 - $551,709	-7,952 Reduced 6.87%	107,788 $7.28 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $376,743 - $422,051	-6,025 Reduced 4.95%	115,740 $7.52 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $545,889 - $712,343	-9,017 Reduced 6.89%	121,765 $7.62 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $403,729 - $447,002	5,664 Added 4.53%	130,782 $10.1 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $7.97 Million - $9.3 Million	-122,828 Reduced 49.54%	125,118 $8.86 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $211,163 - $257,431	-2,899 Reduced 1.16%	247,946 $18.7 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $72,217 - $84,772	-1,015 Reduced 0.4%	250,845 $18 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $18.2 Million - $21.5 Million	251,860	251,860 $20.4 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account